The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Gillingham, Peter Jason Maurice
    Individual (1 offspring)
    Officer
    2004-04-10 ~ now
    OF - Secretary → CIF 0
  • 2
    Smith, Fiona Sheenagh
    Clinical Research born in December 1961
    Individual (1 offspring)
    Officer
    2004-02-16 ~ now
    OF - Director → CIF 0
    Fiona Sheenagh Smith
    Born in December 1961
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 1
  • Windsor, Francesca
    Individual (8 offsprings)
    Officer
    2004-02-16 ~ 2004-04-10
    OF - Secretary → CIF 0
parent relation
Company in focus

FSS CLINICAL RESEARCH LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Debtors
3,304 GBP2024-03-31
10,704 GBP2023-03-31
Cash at bank and in hand
223,936 GBP2024-03-31
229,925 GBP2023-03-31
Current Assets
227,240 GBP2024-03-31
240,629 GBP2023-03-31
Creditors
Current
6,050 GBP2024-03-31
15,325 GBP2023-03-31
Net Current Assets/Liabilities
221,190 GBP2024-03-31
225,304 GBP2023-03-31
Total Assets Less Current Liabilities
221,190 GBP2024-03-31
225,304 GBP2023-03-31
Equity
Called up share capital
100 GBP2024-03-31
100 GBP2023-03-31
Retained earnings (accumulated losses)
221,090 GBP2024-03-31
225,204 GBP2023-03-31
Equity
221,190 GBP2024-03-31
225,304 GBP2023-03-31
Average Number of Employees
22023-04-01 ~ 2024-03-31
22022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
2,324 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
2,324 GBP2023-03-31
Trade Debtors/Trade Receivables
Amounts falling due within one year, Current
1,661 GBP2024-03-31
7,918 GBP2023-03-31
Other Debtors
Amounts falling due within one year, Current
1,643 GBP2024-03-31
2,786 GBP2023-03-31
Debtors
Amounts falling due within one year, Current
3,304 GBP2024-03-31
10,704 GBP2023-03-31
Other Taxation & Social Security Payable
Current
1,915 GBP2024-03-31
9,664 GBP2023-03-31
Other Creditors
Current
4,135 GBP2024-03-31
5,661 GBP2023-03-31

  • FSS CLINICAL RESEARCH LIMITED
    Info
    Registered number 05045708
    Parkway House, Palatine Road, Manchester M22 4DB
    Private Limited Company incorporated on 2004-02-16 (21 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-16
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.